Skip to content

Clinical trials

Phase 3 Multiple Myeloma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 3 Country / region: France Clear all

102 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20023
20032
20041
20052
20061
20084
20091
20103
20115
20123
20135
20143
20155
20162
20177
20183
20196
20204
20215
20229
20235
20247
20252
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Active, not recruiting25
Recruiting18
Terminated4
Not yet recruiting2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC16
Celgene13
Amgen8
AbbVie5
Intergroupe Francophone du Myelome4
Millennium Pharmaceuticals, Inc.4
Pfizer4
Sanofi4
AstraZeneca3
European Organisation for Research and Treatment of Cancer - EORTC3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma102
Recurrence19
Neoplasms, Plasma Cell9
Lymphoma, Non-Hodgkin6
Leukemia, Lymphocytic, Chronic, B-Cell5
Neoplasms5
Burkitt Lymphoma4
Leukemia, Myeloid, Acute4
Lymphoma4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4

Trials

Showing 1 to 25 of 102. Each trial links to its page on Pharma Observatory.

2 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.